These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18319266)

  • 21. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Impact of Cardiac Magnetic Resonance Imaging Versus Echocardiography-Guided Patient Selection for Primary Prevention Implantable Cardioverter Defibrillator Therapy.
    Rijnierse MT; van der Lingen AL; Weiland MT; de Haan S; Nijveldt R; Beek AM; van Rossum AC; Allaart CP
    Am J Cardiol; 2015 Aug; 116(3):406-12. PubMed ID: 26050137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of early death after myocardial infarction in patients with reduced left ventricular ejection fraction. The search for new indications for cardioverter-defibrillator implantation (ICD).
    Pres D; Tajstra M; Mitkowski P; Ciślak A; Bujak K; Kaźmierczak J; Sterliński M; Mizia-Stec K; Sierpiński R; Gąsior M; Szumowski Ł; Kalarus Z
    Kardiol Pol; 2021; 79(12):1343-1352. PubMed ID: 34897630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ; Borleffs CJ; Liem SS; Bax JJ; van der Hoeven BL; Bootsma M; van der Wall EE; van Erven L; Schalij MJ
    Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?].
    Lercher P; Rotman B; Scherr D; Kraxner W; Luha O; Klein W
    Wien Klin Wochenschr; 2003 Mar; 115(5-6):167-74. PubMed ID: 12741076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of sudden cardiac death risk in the very early postmyocardial infarction period.
    Daoud EG; Hummel JD; Rhodes TE
    Curr Opin Cardiol; 2010 May; 25(3):253-61. PubMed ID: 22393566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there unmet need for implantable cardioverter defibrillators? Findings from a post-mortem series of sudden cardiac death.
    Chase D; Roderick PJ; Burnley H; Gallagher PJ; Roberts PR; Morgan JM
    Europace; 2008 Jun; 10(6):741-6. PubMed ID: 18467301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).
    Santini M; Russo M; Botto G; Lunati M; Proclemer A; Schmidt B; Erdogan A; Helmling E; Rauhe W; Desaga M; Santi E; Messier M; Boriani G
    Europace; 2009 Apr; 11(4):476-82. PubMed ID: 19136492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death.
    Das MK; Gaitonde R; Miller JM
    Curr Cardiol Rep; 2007 Sep; 9(5):371-80. PubMed ID: 17877932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
    Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of current implantable cardioverter defibrillator guidelines application for primary prevention of sudden cardiac death in Latin American patients with heart failure: a cross-sectional study.
    Gonzalez-Zuelgaray J; Pellizon O; Muratore CA; Oropeza ES; Rabinovich R; Ramos JL; Tentori MC; Reyes N; Aguayo R; Marin J; Peterson BJ
    Europace; 2013 Feb; 15(2):236-42. PubMed ID: 22968848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.
    Waks JW; Buxton AE
    Annu Rev Med; 2018 Jan; 69():147-164. PubMed ID: 29414264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system.
    Johnson BK; Garberich RF; Henry TD; Katsiyiannis WT; Sengupta J; Kalra A; Hauser RG; Lardy ME; Newell MC
    Heart Rhythm; 2016 Feb; 13(2):538-46. PubMed ID: 26576706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.